Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Very nice

$ADMA Biologics (ADMA.US)$ ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update

2Q 2024 Total Revenue of $107.2 Million, a 78% Increase Y-o-Y

2Q 2024 GAAP Net Income of $32.1 Million, a $38.4 Million Increase Y-o-Y

2Q 2024 Adjusted EBITDA(1) of $44.5 Million, a Nearly 600% Increase Y-o-Y

Commercial Scale Production of ADMA’s Innovative Biologics Manufacturing Process Supports a Potential Yield Enhancement of Approximately 20% from Same Starting Plasma

FY 2024 and 2025 Total Revenue Guidance Increased to More Than $400 Million and $445 Million, Respectively

FY 2024 GAAP Net Income Guidance Increased to More Than $105 Million and Adjusted EBITDA Guidance Increased to More Than $150 Million

FY 2025 GAAP Net Income Guidance Increased to More than $155 Million and Adjusted EBITDA Guidance Increased to More Than $200 Million

Conference Call Scheduled for Today at 4:30 p.m. ET

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
3
Translate
Report
2595 Views
Comment
Sign in to post a comment
2705Followers
29Following
37KVisitors
Follow